No association of GSTP1 rs1695 polymorphism with amyotrophic lateral sclerosis: A case-control study in the Brazilian population
Authors:
- Jéssica Barletto de Sousa BarrosJBJéssica Barletto de Sousa Barros
- Kamilla de Faria SantosKSKamilla de Faria Santos
- Rômulo Morais AzevedoRARômulo Morais Azevedo
- Rayana Pereira Dantas de OliveiraRORayana Pereira Dantas de Oliveira
- Ana Carolina Dourado LeobasALAna Carolina Dourado Leobas
- Dhiogo da Cruz Pereira BentoDBDhiogo da Cruz Pereira Bento
- Rodrigo da Silva SantosRSRodrigo da Silva Santos
- Angela Adamski da Silva ReisARAngela Adamski da Silva Reis
Open Access
- 19 February 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0247024
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease that affects motor neurons and promotes progressive muscle atrophy. It has a multifactorial etiology, where environmental conditions playing a remarkable role through the increase of oxidative stress. Genetic polymorphisms in cell detoxification genes, such asGlutathione S-Transferase Pi 1(GSTP1) can contribute to excessive oxidative stress, and therefore may be a risk factor to ALS. Thus, this study aimed to investigate the role of theGSTP1rs1695 polymorphism in ALS susceptibility in different genetic inheritance models and evaluate the association of the genotypes with risk factors, clinical and demographic characteristics of ALS patients from the Brazilian central population. This case-control study was conducted with 101 patients with ALS and 101 healthy controls.GSTP1rs1695 polymorphism genotyping was performed with Polymerase Chain Reaction–Restriction Fragment Length Polymorphism (PCR-RFLP). The statistical analysis was carried out using the SPSS statistical package and SNPStats software. Analysis of genetic inheritance models was performed by logistic regression, which was used to determine the Odds Ratio. The results of this first study in the Brazilian population demonstrated that there was no risk association between the development of ALS and theGSTP1rs1695 polymorphism in any genetic inheritance model (codominant, dominant, recessive, overdominant, and logarithmic); and that the polymorphic variants were not associated with the clinical and demographic characteristics of ALS patients. No association of theGSTP1rs1695 polymorphism and ALS development in the Brazilian central population was found. These findings may be justified by the multifactorial character of the disease.Keywords
This publication has 51 references indexed in Scilit:
- Revisiting the Genetic Ancestry of Brazilians Using Autosomal AIM-IndelsPLOS ONE, 2013
- Glutamatergic targets for new alcohol medicationsPsychopharmacology, 2013
- Genetics of amyotrophic lateral sclerosis: an updateMolecular Neurodegeneration, 2013
- Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published LiteratureNeuroepidemiology, 2013
- Amyotrophic lateral sclerosis: A hormonal condition?Amyotrophic Lateral Sclerosis, 2012
- The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than ExpectedPLOS ONE, 2011
- Smoking and Risk of Amyotrophic Lateral SclerosisArchives of Neurology, 2011
- STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statementGenetic Epidemiology, 2009
- Prognostic factors in ALS: A critical reviewAmyotrophic Lateral Sclerosis, 2009
- Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosisClinica Chimica Acta, 2006